Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells

Pengxiang Zhu, Ryuji Hata, Masahito Ogasawara, Fang Cao, Kenji Kameda, Kohei Yamauchi, Alfred H. Schinkel, Kazutaka Maeyama, Masahiro Sakanaka

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The organic cation transporters OCT1, 2, and 3 (SLC22A1-3) have been implicated in the elimination of biogenic amines such as histamine. Among them, OCT3 was identified as an uptake-2 transporter, responsible for clearance of histamine. Because increasing evidence suggests the involvement of histamine in cerebral ischemia, we investigated the effects of targeted disruption of organic cation transporter-3 (Oct3) on the severity of ischemic brain damage. Transient focal ischemia for 1 hour was induced by occlusion of the middle cerebral artery (MCA) of homozygous Oct3-deficient mice and their wild-type (Wt) littermates. Although targeted disruption of Oct3 did not affect physiological parameters after MCA occlusion, this disruption significantly increased histamine content in the ischemic cortex and significantly reduced the infarct volume after cerebral ischemia. Furthermore, targeted disruption of Oct3 prevented the reduction of regulatory T-cell proportion after cerebral ischemia while this disruption did not affect Th1 and Th2 cells proportions after ischemia. Since repeated administration of L-histidine (a precursor of histamine) to Wt mice also showed the same effects, our observations suggested that OCT3 is the molecule responsible for clearance of ischemia-induced histamine in the brain and targeted disruption of Oct3 ameliorated ischemic brain damage through an increase in regulatory T cells.

Original languageEnglish
Pages (from-to)1897-1908
Number of pages12
JournalJournal of Cerebral Blood Flow and Metabolism
Volume32
Issue number10
DOIs
Publication statusPublished - 01-10-2012

Fingerprint

Regulatory T-Lymphocytes
Histamine
Cations
Brain
Brain Ischemia
Ischemia
Middle Cerebral Artery Infarction
Th2 Cells
Th1 Cells
Biogenic Amines
Histidine

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Zhu, Pengxiang ; Hata, Ryuji ; Ogasawara, Masahito ; Cao, Fang ; Kameda, Kenji ; Yamauchi, Kohei ; Schinkel, Alfred H. ; Maeyama, Kazutaka ; Sakanaka, Masahiro. / Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells. In: Journal of Cerebral Blood Flow and Metabolism. 2012 ; Vol. 32, No. 10. pp. 1897-1908.
@article{6d3b87f6f3524995b227d0ec34aafd96,
title = "Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells",
abstract = "The organic cation transporters OCT1, 2, and 3 (SLC22A1-3) have been implicated in the elimination of biogenic amines such as histamine. Among them, OCT3 was identified as an uptake-2 transporter, responsible for clearance of histamine. Because increasing evidence suggests the involvement of histamine in cerebral ischemia, we investigated the effects of targeted disruption of organic cation transporter-3 (Oct3) on the severity of ischemic brain damage. Transient focal ischemia for 1 hour was induced by occlusion of the middle cerebral artery (MCA) of homozygous Oct3-deficient mice and their wild-type (Wt) littermates. Although targeted disruption of Oct3 did not affect physiological parameters after MCA occlusion, this disruption significantly increased histamine content in the ischemic cortex and significantly reduced the infarct volume after cerebral ischemia. Furthermore, targeted disruption of Oct3 prevented the reduction of regulatory T-cell proportion after cerebral ischemia while this disruption did not affect Th1 and Th2 cells proportions after ischemia. Since repeated administration of L-histidine (a precursor of histamine) to Wt mice also showed the same effects, our observations suggested that OCT3 is the molecule responsible for clearance of ischemia-induced histamine in the brain and targeted disruption of Oct3 ameliorated ischemic brain damage through an increase in regulatory T cells.",
author = "Pengxiang Zhu and Ryuji Hata and Masahito Ogasawara and Fang Cao and Kenji Kameda and Kohei Yamauchi and Schinkel, {Alfred H.} and Kazutaka Maeyama and Masahiro Sakanaka",
year = "2012",
month = "10",
day = "1",
doi = "10.1038/jcbfm.2012.92",
language = "English",
volume = "32",
pages = "1897--1908",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "10",

}

Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells. / Zhu, Pengxiang; Hata, Ryuji; Ogasawara, Masahito; Cao, Fang; Kameda, Kenji; Yamauchi, Kohei; Schinkel, Alfred H.; Maeyama, Kazutaka; Sakanaka, Masahiro.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 32, No. 10, 01.10.2012, p. 1897-1908.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells

AU - Zhu, Pengxiang

AU - Hata, Ryuji

AU - Ogasawara, Masahito

AU - Cao, Fang

AU - Kameda, Kenji

AU - Yamauchi, Kohei

AU - Schinkel, Alfred H.

AU - Maeyama, Kazutaka

AU - Sakanaka, Masahiro

PY - 2012/10/1

Y1 - 2012/10/1

N2 - The organic cation transporters OCT1, 2, and 3 (SLC22A1-3) have been implicated in the elimination of biogenic amines such as histamine. Among them, OCT3 was identified as an uptake-2 transporter, responsible for clearance of histamine. Because increasing evidence suggests the involvement of histamine in cerebral ischemia, we investigated the effects of targeted disruption of organic cation transporter-3 (Oct3) on the severity of ischemic brain damage. Transient focal ischemia for 1 hour was induced by occlusion of the middle cerebral artery (MCA) of homozygous Oct3-deficient mice and their wild-type (Wt) littermates. Although targeted disruption of Oct3 did not affect physiological parameters after MCA occlusion, this disruption significantly increased histamine content in the ischemic cortex and significantly reduced the infarct volume after cerebral ischemia. Furthermore, targeted disruption of Oct3 prevented the reduction of regulatory T-cell proportion after cerebral ischemia while this disruption did not affect Th1 and Th2 cells proportions after ischemia. Since repeated administration of L-histidine (a precursor of histamine) to Wt mice also showed the same effects, our observations suggested that OCT3 is the molecule responsible for clearance of ischemia-induced histamine in the brain and targeted disruption of Oct3 ameliorated ischemic brain damage through an increase in regulatory T cells.

AB - The organic cation transporters OCT1, 2, and 3 (SLC22A1-3) have been implicated in the elimination of biogenic amines such as histamine. Among them, OCT3 was identified as an uptake-2 transporter, responsible for clearance of histamine. Because increasing evidence suggests the involvement of histamine in cerebral ischemia, we investigated the effects of targeted disruption of organic cation transporter-3 (Oct3) on the severity of ischemic brain damage. Transient focal ischemia for 1 hour was induced by occlusion of the middle cerebral artery (MCA) of homozygous Oct3-deficient mice and their wild-type (Wt) littermates. Although targeted disruption of Oct3 did not affect physiological parameters after MCA occlusion, this disruption significantly increased histamine content in the ischemic cortex and significantly reduced the infarct volume after cerebral ischemia. Furthermore, targeted disruption of Oct3 prevented the reduction of regulatory T-cell proportion after cerebral ischemia while this disruption did not affect Th1 and Th2 cells proportions after ischemia. Since repeated administration of L-histidine (a precursor of histamine) to Wt mice also showed the same effects, our observations suggested that OCT3 is the molecule responsible for clearance of ischemia-induced histamine in the brain and targeted disruption of Oct3 ameliorated ischemic brain damage through an increase in regulatory T cells.

UR - http://www.scopus.com/inward/record.url?scp=84867089276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867089276&partnerID=8YFLogxK

U2 - 10.1038/jcbfm.2012.92

DO - 10.1038/jcbfm.2012.92

M3 - Article

C2 - 22739622

AN - SCOPUS:84867089276

VL - 32

SP - 1897

EP - 1908

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 10

ER -